5-(propan-2-yloxy)pyridine-3-carboxylic acid, 95.0%, 1g

tert-Butyl 4-bromo-1-naphthoate, 95.0%, 5g

Phenylbutazone>98.0%(HPLC)(T)25g

4-BROMOISOQUINOLIN-8-OL, 95.0%, 1g

(2E)-1-(2,4-dimethylphenyl)-3-(4-ethylphenyl)prop-2-en-1-one, 95.0%, 2g

Tetrakis(dimethylamido)diboron, 95.0%, 5g

BROMO-PEG2-ALCOHOL, 95.0%, 250mg

[2-(6,7-dimethyl-1H-benzimidazol-2-yl)ethyl]amine hydrochloride, 95.0%, 1g

GC capillary column ROTI®Cap-1701, 60 m, 0.32 mm, 0.35 µm, 1 Piece(s)

2-Iodo-4-nitro-1H-indole, 97%, 100mg

1-(1,1-Difluoroethyl)-2,4-difluorobenzene, 1g

2-Chloro-4-(4-chlorophenyl)thiazole, 98.0%, 1g

2,3,5-Triiodobenzaldehyde, 97.0%, 5g